Workers in emerging countries such as India and Brazil are more confident about digital skills than those in developed markets, a survey has found.
Research carried out by Barclays also showed that while 38 per cent of British workers said their employer offered training in digital skills, that figure is considerably higher in India (67 per cent), China and the US (both 48 per cent).
India also has the most number of school pupils proficient in coding, the Barclays Digital Development Index found. It carried out an assessment in 10 countries of workers’ digital skills and national efforts to drive a digital agenda for the workforce.
Estonia and South Korea came on top of the list, with the UK ranked fourth and India seventh. Sweden was placed fourth while China and the US were tied in fifth place.
Ashok Vaswani, the CEO of Barclays UK, said: “The old ways of doing things will become obsolete. Traditional skills are less relevant, and businesses grow or fail at speeds never previously thought possible.
“In this new world of disruptive innovation and digital advancement, it is those individuals, businesses and societies who have the greatest level of access, ability and understanding who will continue to prosper. Those which have the least will fall behind and find it progressively harder to catch up.”
Findings from the survey showed that workers in India were more confident of their digital skills in web search and evaluation, communication and collaboration, as well as protecting data and devices.
British workers rated themselves particularly poorly on researching and evaluating information and protecting data and devices (ninth in both cases).
The analysis is significant given the scale of online fraud in the UK. Last week, the Office for National Statistics (ONS) said almost six million fraud and cyber crimes were committed in 2015 in England and Wales.
In the area of content creation and coding, Indian workers were top of the list, while the UK was seventh. India produced the most school pupils with coding skills, almost 10 times as many as the US.
The survey found that there was a shortage of skilled IT teachers in Britain, and as a result there was an increased reliance on volunteers.
Hasan Bakhshi, senior director, creative economy and data analytics at Nesta, an innovation charity, said formal education was vital for developing digital empowerment among citizens and workers:
“Digital education starts in the home and in school,” he said.
“We have seen a number of positive changes in recent years, in the implementation of the computing curriculum and the proliferation of coding clubs. Still, more can be done to keep the UK competitive globally, and some of these things involve thinking of the different digital skills the economy requires.”
According to the House of Commons Science and Technology Committee, the digital skills gap is costing the UK economy an estimated £63 billion a year in lost additional GDP.
Last year, the House of Lords Select Committee warned Britain must address its digital skills shortage or face losing its place as a global digital leader.
UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.
Investment gap
Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.
Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.
Richard Torbett, ABPI Chief Executive, noted “The UK can lead globally in medicines and vaccines, unlocking billions in R&D investment and improving patient access but only if barriers are removed and innovation rewarded.”
The UK invests just 9% of healthcare spending in medicines, compared with 17% in Spain, and only 37% of new medicines are made fully available for their licensed indications, compared to 90% in Germany.
Expert reviews
Shailesh Solanki, executive editor of Pharmacy Business, pointed that “The government’s own review shows the sector is underfunded by about £2 billion per year. To make transformation a reality, this gap must be closed with clear plans for investment in people, premises and technology.”
The National Institute for Health and Care Excellence (NICE) cost-effectiveness threshold £20,000 to £30,000 per Quality-Adjusted Life Year (QALY) — has remained unchanged for over two decades, delaying or deterring new medicine launches. Raising it is viewed as vital to attracting foreign investment, expanding patient access, and maintaining the UK’s global standing in life sciences.
Guy Oliver, General Manager for Bristol Myers Squibb UK and Ireland, noted that " the current VPAG rate is leaving UK patients behind other countries, forcing cuts to NHS partnerships, clinical trials, and workforce despite government growth ambitions".
Reeves’ push for reform, supported by the ABPI’s Competitiveness Framework, underlines Britain’s intent to stay a leading hub for pharmaceutical innovation while ensuring NHS patients will gain faster access to new treatments.
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.